For more than 20 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. This vital role bridges Data Science, Discovery, and Early Translational Research departments, requiring collaboration with a world-class, international team adept in oncology, immunology, and advanced computational methods.